Filing Details
- Accession Number:
- 0001209191-21-018651
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-08 17:47:25
- Reporting Period:
- 2021-03-05
- Accepted Time:
- 2021-03-08 17:47:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1347178 | Vanda Pharmaceuticals Inc. | VNDA | Pharmaceutical Preparations (2834) | 030491827 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1748392 | Timothy Williams | C/O Vanda Pharmaceuticals Inc. 2200 Pennsylvania Avenue, Suite 300E Washington DC 20037 | Svp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-03-05 | 200 | $17.88 | 92,326 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-05 | 5,400 | $17.85 | 86,926 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Billionaire Hedge Funds
